Oramed Pharmaceuticals Inc.
ORMP
$2.75
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 134.69M | 97.94M | 130.64M | 141.93M | 142.30M |
| Total Receivables | 402.00K | 611.00K | 208.00K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.03M | 475.00K | 624.00K | 1.29M | 474.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 136.12M | 99.03M | 131.48M | 143.22M | 142.77M |
|
|
|||||
| Total Current Assets | 136.12M | 99.03M | 131.48M | 143.22M | 142.77M |
| Net Property, Plant & Equipment | 1.43M | 1.53M | 1.01M | 1.11M | 1.20M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.09M | 4.52M | 5.52M | 34.00K | 32.00K |
| Total Assets | 220.49M | 161.68M | 147.54M | 155.28M | 165.08M |
|
|
|||||
| Total Accounts Payable | 560.00K | 715.00K | 509.00K | 789.00K | 5.00M |
| Total Accrued Expenses | 819.00K | 1.13M | 1.01M | 1.48M | 35.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 271.00K | 264.00K | 181.00K | 216.00K | 243.00K |
| Total Finance Division Other Current Liabilities | 4.47M | 1.58M | 3.79M | 3.20M | -- |
| Total Other Current Liabilities | 4.47M | 1.58M | 3.79M | 3.20M | -- |
| Total Current Liabilities | 6.12M | 3.69M | 5.49M | 5.69M | 5.27M |
|
|
|||||
| Total Current Liabilities | 6.12M | 3.69M | 5.49M | 5.69M | 5.27M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 589.00K | 648.00K | 120.00K | 156.00K | 186.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.46M | 3.76M | 2.03M | 4.09M | 4.10M |
| Total Liabilities | 18.16M | 8.10M | 7.65M | 9.93M | 9.56M |
|
|
|||||
| Common Stock & APIC | 325.86M | 325.50M | 325.07M | 322.88M | 322.87M |
| Retained Earnings | -122.58M | -170.97M | -184.26M | -176.62M | -166.43M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 203.28M | 154.53M | 140.81M | 146.27M | 156.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 203.28M | 154.53M | 140.81M | 146.27M | 156.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -952.00K | -946.00K | -918.00K | -918.00K | -919.00K |
| Total Equity | 202.33M | 153.58M | 139.89M | 145.35M | 155.52M |
|
|
|||||